KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Preferred Shares (2020 - 2025)

LifeMD filings provide 6 years of Preferred Shares readings, the most recent being $140.0 for Q4 2025.

  • On a quarterly basis, Preferred Shares changed 0.0% to $140.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $140.0, a 0.0% change, with the full-year FY2025 number at $140.0, changed 0.0% from a year prior.
  • Preferred Shares hit $140.0 in Q4 2025 for LifeMD, roughly flat from $140.0 in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $1175.0 in Q4 2021 to a low of $140.0 in Q1 2022.
  • Median Preferred Shares over the past 5 years was $140.0 (2022), compared with a mean of $200.88.
  • Biggest five-year swings in Preferred Shares: plummeted 88.09% in 2022 and later changed 0.0% in 2023.
  • LifeMD's Preferred Shares stood at $1175.0 in 2021, then plummeted by 88.09% to $140.0 in 2022, then changed by 0.0% to $140.0 in 2023, then changed by 0.0% to $140.0 in 2024, then changed by 0.0% to $140.0 in 2025.
  • The last three reported values for Preferred Shares were $140.0 (Q4 2025), $140.0 (Q3 2025), and $140.0 (Q2 2025) per Business Quant data.